Filing Flows › Apyx Medical (APYX) › Q1 2026
Apyx Medical (APYX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Apyx Medical (APYX) reported revenue of $12.5M for the first quarter 2026 (Q1 2026), +32% from a year earlier and -35% from the quarter before. Operating margin was -7.3%, net loss $2.1M (17.2% of revenue).
Apyx Medical, Q1 2026: revenue $12.5M (+32% year over year), operating margin -7.3%, net loss $2.1M, operating cash flow −$572K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.5M | -35% | +32% |
| Operating profit | −$911K | -8382% | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$572K | — | — |
What changed
Revenue was $12.5M in Q1 2026, up 32% year over year and down 35% from the previous quarter.
Gross margin was 63.5%, up 3.4 points from Q1 2025. Operating costs exceeded revenue by $911K, an operating margin of -7.3%. Operating expenses grew 1% against revenue growth of 32%. The quarter ended with a net loss of $2.1M, wider than the previous quarter's $1.2M loss. Minority interests bore $35K of it: to shareholders the quarter was a loss of $2.1M. Net interest and other expense of $1.1M was the main reason.
Operating cash flow was −$572K. Non-cash charges added back $202K of depreciation and amortization and $312K of share-based compensation. Working capital and other items added $1.1M. Capital expenditures of $60K exceeded it, leaving free cash flow of −$632K.
Questions
What was Apyx Medical's revenue in the first quarter 2026?
Apyx Medical (APYX) reported revenue of $12.5M for the first quarter 2026 (Q1 2026), +32% from a year earlier and -35% from the quarter before.
Was Apyx Medical profitable in the first quarter 2026?
Operating loss was $911K (-7.3% of revenue) and net loss $2.1M.
Source: Apyx Medical 10-Q on SEC EDGAR.